Slovak
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
angina pectoris/mŕtvica
Odkaz sa uloží do schránky
Strana 1 od 55 výsledky
Novel 2-thienyloxyacetic acid derivatives, a process for their preparation and pharmaceutical preparations containing them
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
DESCRIPTION
The invention relates to novel 2-thienyloxyacetic acid derivatives, a process for their preparation and pharmaceutical preparations containing these substances.
Substances with an antithrombotic action have already been known for a relatively long time. Thus, for example, acetylsalicylic
Method of treatment and pharmaceutical composition
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
The present invention relates to a pharmaceutical composition comprising as active ingredients
(i) the AT.sub.1 receptor antagonist (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl)bi phenyl-4-yl-methyl]amine (valsartan) of formula (I) ##STR1##
or a pharmaceutically acceptable
Method of treatment and pharmaceutical composition
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
The present invention relates to a pharmaceutical composition comprising as active ingredients
(i) the AT.sub.1 receptor antagonist (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl)bi phenyl4-yl-methyl]amine (valsartan) of formula (I) ##STR1##
or a pharmaceutically acceptable
Pharmaceutical composition with antibody that binds to heat shock protein 27(HSP270) and method for promoting wound healing
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. National Stage of International Application No. PCT/KR2011/006065, filed Aug. 18, 2011, which claims priority to and the benefit of Korean Patent Application No. 10-2010-0079857, filed Aug. 18, 2010, which is hereby incorporated by
Methods of treatment and pharmaceutical composition
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION
The renin angiotensin system is a complex hormonal system comprised of a large molecular weight precursor, angiotensinogen, two processing enzymes, renin and angiotensin converting enzyme (ACE), and the vasoactive mediator angiotensin II (Ang II). See J. Cardiovasc.
Methods of treatment and pharmaceutical composition
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION
The renin angiotensin system is a complex hormonal system comprised of a large molecular weight precursor, angiotensinogen, two processing enzymes, renin and angiotensin converting enzyme (ACE), and the vasoactive mediator angiotensin II (Ang II). See J. Cardiovasc.
Aza-amino acid derivatives (factor Xa inhibitors 15)
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
The invention relates to semicarbazides of the general formula I, ##STR2##
where: R.sup.1 is --(CH.sub.2).sub.n --NH.sub.2, --CON.dbd.C(NH.sub.2).sub.2, --NHC(.dbd.NH)--NH.sub.2 or --C(.dbd.NH)--NH.sub.2, which can also be monosubstituted by --OH, --OCOOA, --OCOO(CH.sub.2).sub.n N(A).sub.2,
Acylated indanyl amines and their use as pharmaceuticals
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
The present invention relates to acylated indanyl amines of the general formula (I), with the definitions of R.sup.1 to R.sup.5 and A and B given below in the text, in any of their stereoisomeric forms or mixtures thereof in any ratio and/or pharmaceutically acceptable salts thereof, and their use
Acylated indanyl amines and their use as pharmaceuticals
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
The present invention relates to acylated indanyl amines of the general formula (I), with the definitions of R.sup.1 to R.sup.5 and A and B given below in the text, in any of their stereoisomeric forms or mixtures thereof in any ratio and/or pharmaceutically acceptable salts thereof, and their use
Acylated indanyl amines and their use as pharmaceuticals
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
The present invention relates to acylated indanyl amines of the general formula (I), with the definitions of R.sup.1 to R.sup.5 and A and B given below in the text, in any of their stereoisomeric forms or mixtures thereof in any ratio and/or pharmaceutically acceptable salts thereof, and their use
Aromatic ring derivatives
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
TECHNICAL FIELD
The present invention relates to novel aromatic ring derivatives and specifically to novel aromatic ring derivatives and their pharmaceutically acceptable salts having blood sugar level-depressing activity or PDE5-inhibiting activity. The present invention also relates to
Benzimidazole derivatives
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
TECHNICAL FIELD
The present invention relates to novel benzimidazole derivatives, and, more precisely, to novel benzimidazole derivatives and their pharmaceutically acceptable salts having blood sugar level-depressing activity or PDE5-inhibiting activity. The present invention also relates to
Benzimidazole compounds
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
TECHNICAL FIELD
The present invention relates to novel benzimidazole derivatives, and, more precisely, to novel benzimidazole derivatives and their pharmaceutically acceptable salts having blood sugar level-depressing activity or PDE5-inhibiting activity. The present invention also relates to
Endothelin-antagonizing peptide
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
FIELD OF THE INVENTION
The present invention relates to a novel peptide which has endothelin-antagonizing activity, and an intermediate for its synthesis. The peptide has excellent endothelin-antagonizing activity, and is therefore useful for treatment of hypertension, asthma, cerebral apoplexy,
Soluble guanylate cyclase activators
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION
Cyclic GMP is an important intracellular messenger which triggers a multitude of different effects via the modulation of cGMP-dependent protein kinases, phosphodiesterases and ion channels. Examples are the relaxation of smooth muscles, the inhibition of thrombocyte
Najkompletnejšia databáza liečivých bylín podporovaná vedou
- Pracuje v 55 jazykoch
- Bylinné lieky podporené vedou
- Rozpoznávanie bylín podľa obrázka
- Interaktívna GPS mapa - označte byliny na mieste (už čoskoro)
- Prečítajte si vedecké publikácie týkajúce sa vášho hľadania
- Vyhľadajte liečivé byliny podľa ich účinkov
- Usporiadajte svoje záujmy a držte krok s novinkami, klinickými skúškami a patentmi
Zadajte príznak alebo chorobu a prečítajte si o bylinách, ktoré by vám mohli pomôcť, napíšte bylinu a pozrite sa na choroby a príznaky, proti ktorým sa používa.
* Všetky informácie sú založené na publikovanom vedeckom výskume
